Featured Collaborative Research Solutions
![[Copy] Eukaryotic mRNA Sequencing-NGS](http://www.bmkgene.com/uploads/%E7%BD%91%E7%AB%99%E4%BA%A7%E5%93%8125.1.14-033.jpg)
Introduction to De Novo Genome Assembly in Academic Research
De novo genome assembly refers to the construction of a genome sequence from scratch without the assistance of a pre-existing reference genome. Unlike resequencing projects, which map reads directly to a known template, de novo assembly utilizes complex mathematical algorithms to align overlapping sequence reads, reconstructing the complete genomic blueprint of an organism. This approach is highly critical for discovering novel structural variations, identifying genomic rearrangements, and constructing reference genomes for non-model organisms.
For academic researchers, de novo assembly represents a gateway to unlocking evolutionary secrets, deciphering complex biological mechanisms, and laying the groundwork for downstream functional genomics. As sequencing technologies have evolved from short-read next-generation sequencing (NGS) to long-read third-generation sequencing (TGS), the accuracy, contiguity, and completeness of de novo assemblies have reached unprecedented levels, transforming fields such as evolutionary biology, comparative genomics, and conservation ecology.
Why Partner with BMKGene?
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics.
Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
Commercial & Industrial Status of De Novo Assembly
The transition of de novo assembly from a specialized academic project to a scalable commercial and industrial workflow has accelerated rapidly over the last decade.
Agriculture & Crop Breeding
Industrial agricultural companies rely on de novo assembly to build high-quality reference genomes for complex polyploid crops (such as wheat, cotton, and sugarcane). These assemblies enable the identification of quantitative trait loci (QTLs) linked to drought resistance, pest tolerance, and yield optimization, speeding up marker-assisted selection and gene-editing programs.
Pharma & Synthetic Biology
In biopharmaceuticals and industrial biotechnology, de novo sequencing of microbial and fungal genomes is crucial for discovering novel biosynthetic gene clusters (BGCs). These clusters code for secondary metabolites, which serve as the foundation for new antibiotics, therapeutic proteins, and bio-based chemicals.
Conservation & Biodiversity
Large-scale international consortia, such as the Earth BioGenome Project (EBP), are driving the commercial demand for high-throughput, cost-effective de novo sequencing. Establishing chromosome-level reference assemblies for eukaryotic species is essential for understanding genetic diversity, tracking evolutionary adaptations, and formulating scientific conservation strategies.
State-of-the-Art Sequencing & Bioinformatics Platforms
To achieve high-contiguity, chromosome-level genome assemblies, a multi-platform integration strategy is often necessary. BMKGene offers access to the industry's most advanced long-read, short-read, and physical mapping technologies, ensuring that researchers can tailor their experimental designs to the specific complexity of their target organisms.
PacBio Long-Read Platforms
Sequel II, Sequel, RSII
PacBio's High-Fidelity (HiFi) reads combine the benefits of long read lengths (up to 20 kb) with high single-molecule sequencing accuracy (>99.9%). This makes them the gold standard for resolving highly repetitive regions, structural variations, and complex gene families in de novo assembly projects.
Oxford Nanopore Platforms
PromethION P48, GridION X5, MinION
Nanopore sequencing provides ultra-long reads (up to several megabases), which are instrumental in spanning extremely long repetitive elements, centromeres, and telomeres, allowing for the reconstruction of gapless, chromosome-level assemblies.
Bioinformatics Infrastructure
Self-developed BMKCloud Platform
Equipped with 4,260 computing cores, 41,104 GB of memory, and 3 PB of total storage, our advanced computational environment features a peak computing power exceeding 121,708.8 Gflop per second. This enables rapid, parallel processing of massive genomic datasets.
Our Platforms Portfolio
By combining short-read sequencing (Illumina NovaSeq and BGI DNBSEQ platforms) with long-read sequencing (PacBio and Oxford Nanopore) and scaffolding technologies (such as Hi-C and the Bionano Irys system), we provide a comprehensive toolkit for resolving even the most challenging genomes, including large, highly repetitive, and polyploid species.
Furthermore, our analytical capabilities extend to advanced proteomic and metabolomic platforms, including the Waters XEVO G2-XS QTOF and QTRAP 6500+, allowing for multi-omics integration that bridges genomic sequences with functional biological phenotypes.
Advanced Molecular Laboratory Standards
BMKGene operates within a state-of-the-art facility spanning over 20,000 square feet, equipped with advanced biomolecular laboratory instruments. Our space is divided into specialized clean rooms, sample extraction zones, library construction labs, and high-throughput sequencing suites. All processes, from sample preparation to final sequencing, are executed under strict Standard Operating Procedures (SOPs) to ensure the highest data quality and reproducibility.
Brilliant Lab 1000: Fully Automated NGS Library Preparation
To maximize throughput and eliminate human error, Biomarker Technologies and PerkinElmer have jointly engineered the Brilliant Lab 1000 (BL1000), a fully automated experimental production line applied to high-throughput NGS library construction.
The BL1000 system automates liquid handling, sample purification, quality control, and library pooling. This integration enables BMKGene to rapidly scale production, improve delivery quality, shorten turnaround times, and expand the diversity of sequencing products available to our global academic and commercial partners.
Watch: Fully Automated Platform for Next-Generation Sequencing - Brilliant Lab 1000
In-Depth Application Scenarios for Academic Collaboration
Academic collaborations with BMKGene leverage de novo genome assembly to address fundamental biological questions. Below are the key scientific areas where our de novo sequencing solutions are driving major breakthroughs:
1. Evolutionary Biology and Pan-Genome Construction
Relying on a single reference genome can lead to reference bias, overlooking significant genetic variation within a species. Through academic cooperation, researchers assemble multiple individuals from diverse geographic populations to build species-specific pan-genomes. This approach uncovers large structural variations (SVs), copy number variations (CNVs), and presence-absence variations (PAVs) that are crucial for understanding adaptive evolution, speciation, and domestication history.
2. Deciphering Complex and Polyploid Plant Genomes
Many economically important plants, such as sugarcane, cotton, and various medicinal herbs, possess complex genomes characterized by high heterozygosity, polyploidy, and massive repetitive sequences. Using a combination of PacBio HiFi reads, Oxford Nanopore ultra-long reads, and Hi-C scaffolding, we assist academic researchers in generating gapless chromosome-level assemblies. These high-quality genomes facilitate the discovery of novel metabolic pathways, secondary metabolite biosynthesis genes, and targets for genetic engineering.
3. Metagenomic De Novo Assembly for Environmental Microbiomes
Standard metagenomics often relies on mapping reads to database references, leaving a large portion of the microbial dark matter uncharacterized. Metagenomic de novo assembly allows researchers to reconstruct metagenome-assembled genomes (MAGs) directly from environmental, clinical, or agricultural samples without cultivation. This is crucial for discovering novel enzymes for industrial biocatalysis, identifying microbial key players in soil health, and understanding host-microbiome interactions in human and animal health.
4. High-Resolution Spatial Transcriptomics and Multi-Omics
By combining chromosome-level de novo genome assemblies with our proprietary BMKMANU S3000 spatial transcriptome technology, researchers can visualize gene expression profiles directly within tissue sections at cellular resolution. This integrated workflow provides a spatial map of gene expression, helping to correlate structural genomic features with localized physiological functions in development, disease progression, and environmental stress responses.
Future Trends in De Novo Genome Assembly
The field of genomics is rapidly moving toward the generation of complete, gapless, and haplotype-resolved reference assemblies, commonly referred to as Telomere-to-Telomere (T2T) genomes. Future trends shaping academic research and industrial applications include:
- T2T Gapless Assemblies: Resolving previously inaccessible centromeric, telomeric, and highly repetitive ribosomal RNA gene clusters using ultra-long reads combined with high-accuracy reads.
- Haplotype-Resolved Assembly: Phasing maternal and paternal chromosomes individually to understand allele-specific expression, genomic imprinting, and structural variations in diploid and polyploid organisms.
- AI-Driven Bioinformatics Pipelines: Utilizing machine learning and deep learning algorithms to optimize assembly graph resolution, correct sequencing errors, and automate gene annotation, dramatically reducing analysis times.
- Cost Democratization: The continuous reduction in sequencing costs per gigabase will enable the de novo assembly of thousands of genomes for non-model organisms, accelerating global biodiversity mapping initiatives.
Enterprise Qualifications & Academic Affiliations
Our commitment to scientific excellence is backed by international certifications, proprietary patents, and collaborative academic workstations established alongside leading global universities.
